44 Years of Experience
Who is Dr. Stevenson, Neonatal-Perinatal Medicine Specialist in Palo Alto, CA?
Dr. David Stevenson, MD is a Neonatal-Perinatal Medicine Specialist, who primarily practices in Palo Alto, CA. He has been practicing for over 44 years and is board certified. Dr. Stevenson is fluent in English, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Stevenson’s office at (650) 497-8000.
Is Dr. Stevenson board certified as a Neonatal-Perinatal Medicine Specialist?
Yes, Dr. David Stevenson, MD is board certified by the American Board of Pediatrics
What languages does Dr. Stevenson speak?
Dr. Stevenson and their clinical team can communicate with patients in the following languages:
English
What conditions does a Neonatal-Perinatal Medicine Specialist like Dr. Stevenson typically treat?
As a Neonatal-Perinatal Medicine Specialist, conditions treated by Dr. David Stevenson may include:
- Cri du Chat
- Down Syndrome
- Fifth Disease
- Tay Sachs Disease
- Triple X Syndrome
- Turner Syndrome
- VRE
- Whooping Cough
Please contact Dr. Stevenson's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Neonatal-Perinatal Medicine Specialist like Dr. Stevenson typically perform?
As a Neonatal-Perinatal Medicine Specialist, procedures performed by Dr. David Stevenson may include:
- 12 Month Well-Baby Checkup
- 15 Month Well-Baby Checkup
- 18 Month Well-Baby Checkup
- 1 Month Well-Baby Checkup
- 24 Month Well-Baby Checkup
- 2 Month Well-Baby Checkup
- 2 Week Well Baby Checkup
- 30 Month Well-Baby Checkup
Please contact Dr. Stevenson's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Stevenson accept my insurance?
Please contact Dr. Stevenson's office to confirm accepted insurance plans.
Where is Dr. Stevenson's office located?
Recognitions
Publications
Transdiscipliry translatiol science and the case of preterm birth
, 2013
Effect of light exposure on metalloporphyrin-treated newborn mice
, 2012
A deficiency in haem oxygese-1 induces foetal growth restriction by placental vasculature defects
, 2012
Metalloporphyrins - an update.
, 2012
Materl Heme Oxygese 1 Regulates Placental Vasculature Development via Angiogenic Factors in Mice
, 2011
Effects of Zinc Deuteroporphyrin Bis Glycol on Newborn Mice After Heme Loading
, 2011
Is phototherapy exposure associated with better or worse outcomes in 501-to 1000
, 2011
Bilirubin Production and the Risk of Bilirubin Neurotoxicity
, 2011
Panhematin provides a therapeutic benefit in experimental pancreatitis
, 2011
In vitro inhibition of heme oxygese isoenzymes by metalloporphyrins
, 2011
Phil Sunshine: Apgar Award recipient.
, 2011
Metalloporphyrins in the magement of neotal hyperbilirubinemia
, 2010
Understanding Neotal Jaundice: A Perspective on Causation
, 2010
Effect of Heme Oxygese-1 Deficiency on Placental Development
, 2009
Dermal Carbon Monoxide Excretion in Neotal Rats During Light Exposure
, 2009
Gastric protection by lansoprazole and the impact of heme oxygese-1 and ferritin.
, 2009
Photoisomers ? Obfuscating factors in clinical peroxidase measurements of unbound bilirubin?
, 2009
Heme oxygese-1 deficiency leads to disrupted response to acute stress in stem cells and progenitors
, 2008
Aggressive vs. conservative phototherapy for infants with extremely low birth weight
, 2008
Inhibition of heme oxygese activity in newborn mice by azalanstat
, 2008
Regulation of materl and fetal hemodymics by heme oxygese in mice
, 2008
Standardized bench method for evaluating the efficacy of phototherapy devices
, 2008
Statin treatment increases formation of carbon monoxide and bilirubin in mice
, 2007
(TA)(n) UGT 1A1 promoter polymorphism
, 2007
The role of Bach1 in the induction of heme oxygese by tin mesoporphyrin
, 2007
American Pediatric Society presidential address 2006: Science on the edge with life in the balance
, 2006
Expression and regulation of heme oxygese isozymes in the developing mouse cortex
, 2006
Concentration of carbon monoxide (CO) in postmortem human tissues
, 2006
Tissue-specific effects of statins on the expression of heme oxygese-1 in vivo
, 2006
Systemic effects of orally-administered zinc and tin
, 2006
Transcutaneous bilirubinometry
, 2006
The effectiveness of oral tin mesoporphyrin prophylaxis
, 2006
Inhaled nitric oxide for premature infants with severe respiratory failure
, 2005
Monitoring age-related susceptibility of young mice to oral Salmonella enterica serovar typhimurium
, 2005
Phototherapy: Current methods and future directions
, 2004
A primer on neotal jaundice.
, 2004
Effects of metalloporphyrins on heme oxygese-1 transcription
, 2003
Heme oxygese-2 protects against lipid peroxidation-mediated cell loss
, 2003
Selection of potential therapeutics based on
, 2002
Carbon monoxide and bilirubin production in neotes
, 2001
Bioluminescence for biological sensing in living mammals
, 1999
FETAL HEMOGLOBIN OF TRANSFUSED NEOTES AND SPECTROPHOTOMETRIC MEASUREMENTS OF OXYHEMOGLOBIN
, 1991
Could genetic polymorphisms related to oxidative stress modulate effects of heavy metals
, 2013
Evaluation of window-tinting films for sunlight phototherapy.
, 2013
The effect of hematocrit on the efficacy of phototherapy for neotal jaundice
, 2013
Predischarge Screening for Severe Neotal Hyperbilirubinemia Identifies Infants Who Need
, 2013
High Quality Genome-Wide Genotyping from Archived Dried Blood Spots without D Amplification.
, 2013
Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia.
, 2013
Introductory address for the John Howland Award recipient, Philip A. Pizzo, MD
, 2012
The Need for Technologies to Prevent Bilirubin-Induced Neurologic Dysfunction Syndrome
, 2011
Heme Oxygese-1 Deletion Affects Stress Erythropoiesis
, 2011
Quantitating carbon monoxide production from heme by vascular plant preparations in vitro
, 2011
Heptavalent Pneumococcal Conjugate Vaccine Immunogenicity in Very-Low-Birth-Weight
, 2010
ELEVATED EXHALED CARBON MONOXIDE CONCENTRATION IN HEMOGLOBINOPATHIES
, 2010
Neotal brain structure on MRI and diffusion tensor imaging, sex
, 2009
Inhaled Nitric Oxide for Preterm Premature Rupture of Membranes, Oligohydramnios
, 2009
Commentary on the bilirubin supplement
, 2009
Safe and effective devices for use in the neotal intensive care unit: NICHD Workshop Summary.
, 2009
Readmission for neotal jaundice in California, 1991-2000: Trends and implications
, 2008
Neotal microstructural development of the interl capsule on diffusion tensor imaging correlates
, 2007
Beware of the weaker sex: Don't get too close to your twin brother
, 2007
Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a r
, 2007
Inhaled nitric oxide in infants > 1500 g and < 34 weeks gestation with severe respiratory failure
, 2007
Interobserver reliability
, 2007
The potential Salmonella aroA(-) vaccine strain is safe and effective in young BALB/c mice
, 2007
Apigenin decreases hemin-mediated heme oxygese-1 induction
, 2005
Determition of carbon monoxide (CO) in rodent tissue
, 2005
NICHD Conference on Kernicterus
Cesarean delivery rates and neotal morbidity in a low-risk population
, 2004
Continuous, noninvasive
, 2004
End tidal carbon monoxide levels are lower in women with gestatiol hypertension and pre-eclampsia.
, 2004
Characterization of coelenterazine alogs for measurements of Renilla luciferase activity
, 2004
Gestatiol pattern of heme oxygese expression in the rat
, 2003
Ethical considerations in neuroimaging and its impact on decision-making for neotes
, 2002
The jaundiced newborn. Understanding and maging transitiol hyperbilirubinemia.
, 2002
Heme oxygese-1 modulates fetal growth in the rat
, 2002
In vivo patterns of heme oxygese-1 transcription.
, 2001
Understanding newborn jaundice.
, 2001
The biology of bilirubin production.
, 2001
Just when you thought it was safe...
, 2001
Altertive metalloporphyrins for the treatment of neotal jaundice.
, 2001
Prediction of hyperbilirubinemia in near-term and term infants.
, 2001
Differing pathogenesis of perital bilirubinemia in glucose-6
, 2001
Prediction of hyperbilirubinemia in near-term and term infants
, 2001
Serum bilirubin levels at 72 hours by selected characteristics in breastfed
, 2001
Unique effects of zinc protoporphyrin on HO-1 induction and apoptosis
, 2001
Neotal hyperbilirubinemia.
, 2001
Rapid in vivo functiol alysis of transgenes in mice using whole body imaging of lucifer
, 2001
Bedside functiol imaging of the premature infant brain during passive motor activation
, 2001
Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage
, 2000
Reduction of the NO-mediated response in the rat aorta by metalloporphyrins
, 2000
Haem oxygese activity in human umbilical cord and rat vascular tissues
, 2000
Noninvasive functiol imaging of human brain using light
, 2000
Carbon monoxide detection and biological investigations.
, 2000
Validation of the tus CO-Stat (TM) end tidal breath alyzer in children and adults
, 1999
Effects of skin-to-skin holding on general movements of preterm infants
, 1999
Bilirubin toxicity and differentiation of cultured astrocytes.
, 1999
Bedside imaging of intracranial hemorrhage in the neote using light
, 1999
Simultaneous production of carbon monoxide
, 1998
Very low birth weight outcomes of the tiol Institute of Child Health
, 1998
Light-emitting diodes: A novel light source for phototherapy
, 1998
Strategy for lipid suppression in lactate imaging using STIR-DQCT
, 1998
Statiory headband for clinical time-of-flight optical imaging at the bedside
, 1998
Diffusion and perfusion magnetic resonce imaging of the evolution of hypoxic ischemic
, 1998
Ethical dilemmas in the delivery room
, 1998
Bioluminescent indicators in living mammals
, 1998
Neotal hypoglycemia, part II: Pathophysiology and therapy
, 1998
Neotal hypoglycemia .1. Background and definition
, 1997
Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of
, 1997
Visualizing gene expression in living mammals using a bioluminescent reporter
, 1997
Carbon monoxide and bilirubin production in neotes
, 1997
Imaging - Tissue optics
, 1997
Development of jaundice in Korean neotes after Cesarean section
, 1997
Neotal severity of illness scoring systems: A comparison
, 1997
The value of neurophysiologic approaches in the anticipation and evaluation of neotal hypoglycemia.
, 1997
The risk of carbon monoxide poisoning after prolonged laparoscopic surgery
, 1996
Nitrovasodilator therapy for severe respiratory distress syndrome.
, 1996
Hepatic heme oxygese is inducible in neotal rats during the early posttal period
, 1996
Interlaboratory variability of bilirubin measurements
, 1996
Duration of action and tissue distribution of zinc protoporphyrin in neotal rats
, 1996
A model for detecting early metabolic changes in neotal asphyxia by 1H-MRS
, 1996
Evaluation of neotal jaundice: monitoring the transition in bilirubin metabolism.
, 1996
Neotal intracranial ischemia and hemorrhage: Diagnosis with US, CT, and MR imaging
, 1996
Characterization of porphyrin heme oxygese inhibitors
, 1996
Imaging brain injury using time-resolved near infrared light scanning
, 1996
Evaluation of a fully automated end-tidal carbon monoxide instrument for breath alysis
, 1996
Is Carbon Monoxide Poisoning a Risk During Prolonged Laparoscopic Surgery?
, 1996
Photonic detection of bacterial pathogens in living hosts
, 1995
HYPERBILIRUBINEMIA RESULTS IN REDUCED OXIDATIVE INJURY IN NEOTAL GUNN-RATS EXPOSED TO HYPEROXIA
, 1995
INDIVIDUALIZED DEVELOPMENTAL CARE FOR VERY-LOW-BIRTH-WEIGHT PREMATURE-INFANTS
, 1995
HOSPITAL READMISSION DUE TO NEOTAL HYPERBILIRUBINEMIA
, 1995
ADVANCES IN THE DIAGNOSIS AND TREATMENT OF NEOTAL HYPERBILIRUBINEMIA
, 1995
RECOMBINT-HUMAN-ERYTHROPOIETIN (RHUEPO) INCREASES TOTAL BILIRUBIN PRODUCTION IN PREMATURE-INFANTS
, 1995
NEOTAL JAUNDICE - WHAT NOW
, 1995
Carbon monoxide and carboxyhemoglobin.
, 1995
SEMIPORTABLE ELECTROCHEMICAL INSTRUMENT FOR DETER
What is Dr. Stevenson's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Stevenson's National Provider Identifier (NPI) number is 1558403790.
What common questions do patients ask about Dr. Stevenson?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Stevenson
What is Dr. David Stevenson's specialty?
Dr. Stevenson is a Neonatal-Perinatal Medicine Specialist near Palo Alto, CA.
What does a Neonatal-Perinatal Medicine Specialist do?
A pediatrician who serves as the primary care provider for sick newborn infants utilizes their clinical expertise for direct patient care and collaborates with obstetrical colleagues to develop care plans for mothers with high-risk pregnancies.
Is this Dr. David Stevenson affiliated with a ranked Castle Connolly Top Hospital?
No, Stevenson is not affiliated with a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Neonatal-Perinatal Medicine Specialist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Neonatal-Perinatal Medicine Specialist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is David Stevenson accepting new patients in Palo Alto, CA?
Yes, Dr. David Stevenson is accepting new patients at this time.
Does Dr. David Stevenson offer online booking?
Please contact Dr. Stevenson's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with David Stevenson?
Please contact Dr. Stevenson's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. David Stevenson have?
Dr. David Stevenson is certified by the American Board of Pediatrics.
Other Neonatal-Perinatal Medicine Specialist Near Palo Alto, CA
Neonatal-Perinatal Medicine Specialist
Accepting patientsHospitalist
Accepting patientsNeonatal-Perinatal Medicine Specialist
Accepting patients